[{"Assets_0_FY_USD":2242844000.0,"CommonStockSharesConverted_0_FY_shares":54738000.0,"CommonStockSharesOutstanding_0_FY_shares":54738000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-413426000.0,"NetIncomeLossConverted_1_FY_USD":-149023000.0,"NetIncomeLossConverted_4_FY_USD":-555625000.0,"StockholdersEquity_0_FY_USD":1885070000.0,"EarningsPerShareBasic_4_FY_USD":-10.68,"EarningsPerShareBasic_1_FY_USD":-2.72,"RevenuesConverted_4_FY_USD":54579000.0,"RevenuesConverted_1_FY_USD":19243000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190221"}]